Avalon Globocare Corp (ALBT)
0.2983
-0.02
(-6.78%)
USD |
NASDAQ |
May 31, 16:00
0.29
-0.01
(-2.78%)
After-Hours: 20:00
Avalon Globocare Research and Development Expense (Quarterly): -0.0005M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0005M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.0178M |
| March 31, 2023 | 0.0924M |
| December 31, 2022 | 0.1898M |
| September 30, 2022 | 0.1704M |
| June 30, 2022 | 0.2545M |
| March 31, 2022 | 0.1167M |
| December 31, 2021 | 0.349M |
| September 30, 2021 | 0.2241M |
| June 30, 2021 | 0.2388M |
| March 31, 2021 | 0.2132M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.2089M |
| September 30, 2020 | 0.2384M |
| June 30, 2020 | 0.1611M |
| March 31, 2020 | 0.2754M |
| December 31, 2019 | 0.4146M |
| September 30, 2019 | 0.2651M |
| June 30, 2019 | 0.9497M |
| March 31, 2019 | 0.1525M |
| December 31, 2018 | 0.0374M |
| September 30, 2018 | 0.0014M |
| June 30, 2018 | 0.0003M |
| March 31, 2018 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
-0.0005M
Minimum
Dec 2023
0.9497M
Maximum
Jun 2019
0.2305M
Average
0.2132M
Median
Mar 2021